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Abstract
Smoking in pregnancy reduces preeclampsia risk, but the mechanism of this effect is unknown. Prior studies have demonstrated that
women with preeclampsia have lower placental adrenomedullin (AM) expression, and cigarette smoke extract (CSE) treatment of
placental trophoblast cells in culture increases AM cellular production. We hypothesized that CSE alters trophoblast invasion
through an AM-mediated mechanism, and that placental AM expression is greater among smokers. HTR-8/SVneo trophoblast cells
were incubated for 24 hours in Matrigel-invasion chambers with 6 treatment groups: nonstimulated (NS), AM, AM inhibitor
(AM22-52), 1% CSE, AMþ AM22-52, and 1% CSEþ AM22-52. Cells that penetrated the lower surface of the chambers were quantified,
invasion indices were calculated, and compared using a 1-way analysis of variance with Bonferroni corrections for multiple com-
parisons. Trophoblast cells treated with both AM and 1% CSE demonstrated increased cellular invasion compared to NS controls
(1.5-fold [P < .01] and 1.45-fold [P < .01], respectively). Cotreatment with the AM inhibitor significantly attenuated the increased
invasion seen with both AM and CSE alone. Next, the placental tissue was obtained from 11 smokers and 11 nonsmokers at term
and processed for immunohistochemistry (IHC) and real-time quantitative polymerase chain reaction (PCR) for AM. Placentas from
smokers demonstrated more intense AM staining and increased AM gene (ADM) expression compared to placentas from non-
smokers (P ¼ .004 for IHC, P ¼ .022 for PCR). The CSE increases trophoblast cell invasion through an AM-mediated process, and
placental AM expression is increased among term smokers compared to nonsmokers. These findings provide evidence that the
AM pathway may play a role in the protection from preeclampsia seen in smokers.
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Introduction
Preeclampsia, characterized by the onset of hypertension and
proteinuria after 20 weeks of gestation, affects approximately
5% to 8% of pregnancies.1 The condition is progressive and can
affect multiple organ systems. Since delivery of the fetus and
placenta is the only treatment option, preeclampsia is a com-
mon etiology of iatrogenic preterm delivery.2 Preeclampsia has
a unique pathophysiology, because it is thought to be due to a
placental factor or abnormality leading to alterations in mater-
nal physiology.3 The process of normal placentation is the
result of trophoblast cell invasion of the maternal decidua and
the establishment of complex vascular networks requiring
extensive angiogenesis.3 It is theorized that inadequate tropho-
blast invasion is the initial event among a complex process
leading to the maternal manifestations of preeclampsia.4
Although the exact cause of preeclampsia remains elusive,
epidemiologic data indicate that smoking during pregnancy
significantly reduces ones risk of developing the disease.5 Frus-
tratingly, how smoking protects the mother from developing
preeclampsia is unknown. Wikstrom et al demonstrated that the
protective effects of smoking on preeclampsia risk are likely to
be due to some combustible product of smoking tobacco rather
than nicotine.6 There are roughly 5000 individual compounds
present in cigarette smoke, making pinpointing 1 causative
agent difficult, although current research has focused on carbon
monoxide and soluble nitric oxide as possible candidates.7-9
Prior work in our laboratory demonstrated that cigarette
smoke extract (CSE) treatment of HTR-8/SVneo trophoblast
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cells causes these treated cells to produce and secrete the
hormone adrenomedullin (AM).10 AM is a 52-amino acid pep-
tide that binds a transmembrane receptor. The AM receptor is a
heterodimer composed of the G protein-coupled receptor
(GPCR) calcitonin-like receptor and GPCR activity-
modifying protein 2.11 AM has multiple functions including
angiogenic, anti-inflammatory, and antimicrobial activities and
has recently emerged as a strong clinical biomarker for a vari-
ety of cardiovascular disease conditions, including myocardial
infarction.12,13 AM is highly expressed in reproductive tissues,
but its role in the pathogenesis of preeclampsia is not fully
understood.14,15 Zhang et al have demonstrated that
AM increases the invasiveness of trophoblast cells in an in vitro
model of invasion, and that this effect is reversible with the
use of the competitive inhibitor AM22-52, a truncated AM mole-
cule that binds, but does not activate, the AM receptor, but
significantly attenuates signaling through the AM receptor.16
Furthermore, our work has demonstrated that CSE treatment
of HTR-8/SVneo trophoblast cells leads to enhanced cellular
viability and migration that are dependent on CSE-mediated
cellular AM production.10
AM expression has been shown to be reduced in the placen-
tas of women with preeclampsia compared to normal con-
trols.17 This finding supports the theory that altered AM
levels in the placenta may mediate the maternal physiologic
changes of preeclampsia. To our knowledge, there have been
no reports comparing AM expression within the placentas of
smokers versus nonsmokers. We hypothesized that CSE
increases the invasiveness of trophoblast cells in vitro via a pro-
cess mediated, at least in part, by AM, and that AM expression




CSE was prepared with a modification of the method described
by Mehendale et al.18 Air was drawn through 3 lit cigarettes
(Marlboro Red; Philip Morris, Richmond, Virginia) with a
vacuum apparatus that bubbled the mainstream smoke through
50 mL of RPMI 1640 cell medium (Mediatech, Inc, Manassas,
Virginia). The medium was then filtered with a 22-mm filter,
and aliquots were stored at 80C and considered 100% CSE.
To normalize CSE concentrations between collections, total
nicotine content was measured by liquid chromatography by
the Center for Nicotine and Smoking Cessation Research, Duke
University Medical Center. The amount of nicotine in each
sample was used to standardize treatments between CSE col-
lections, although all experiments described here utilized CSE
from a single collection.
Cell Culture
An immortalized first-trimester human cytotrophoblast cell
line (HTR-8/SVneo; a gift from Dr C.H. Graham, Queen’s
University, Kingston, Ontario, Canada)19 was cultured in
RPMI 1640 supplemented with 5% fetal bovine serum and
maintained in a humidified 5% CO2 incubator at 37
C. The
cells were trypsinized with 0.05% trypsin-EDTA (Gibco, Life
Technologies, Carlsbad, California).
Matrigel Invasion Assay
Invasion of HTR-8/SVneo trophoblast cells was measured
using 24-well Matrigel-invasion chamber plates (35-4480;
Becton Dickinson Labware, Bedford, Massachusetts) in accor-
dance with the published methods.20,21 The cells (8 104 cells/
well) were plated in the upper chamber of the Matrigel-coated
insert in a total volume of 500 mL of serum-free RPMI 1640
media supplemented with 0.1% bovine serum albumin. To
measure and control for migration, the cells were also plated
at the same density in non-Matrigel-coated control 8.0 mm pore
polyethylene terephthalate membranes cell culture inserts
(35-4578; Becton Dickinson Labware). Two Matrigel-coated
and 2 non-Matrigel-coated inserts were utilized for each run
of the experiment, and the experiment was performed in quad-
ruplicate. Six treatment groups were created for each run of the
experiment: nonstimulated (NS), AM, AM inhibitor (AM22-52),
1% CSE, AM þ AM22-52, and 1% CSE þ AM22-52. In the total
volume of 500 mL media in the upper chamber was added noth-
ing for NS, AM 107 mol/L (AM1-52; American Peptide Com-
pany, Sunnyvale, California), AM22-52 10
6 mol/L (AM22-52;
American Peptide Company), 1% CSE, AM þ AM22-52, and
1% CSE þ AM22-52. The dosing for AM (107 mol/L) and
AM22-52 (10
6 mol/L) were selected based on our previous
work.10 The AM22-52 is a competitive inhibitor of the AM
receptor and so was utilized in 10-fold higher concentration
compared to AM. To the lower chamber was added 750 mL
of RPMI 1640 supplemented with 5% serum that acted as a
chemoattractant. The cells were then incubated at 37C with
5% CO2 for 24 hours. Noninvasive cells on the upper surface
of the chambers were then wiped away with a sterile cotton-
tipped applicator, and any remaining cells were removed from
the rim of the chamber with a sterile 200 mL pipette tip. Cells
on the lower surface of the chamber were then quantified using
the CellTiter 96 AQueous Non-Radioactive Cell Proliferation
Assay (G5421; Promega, Madison, Wisconsin) by placing each
individual chamber into the inverted cap of a cryovial to
which 200 mL of phenol-red-free RMPI 1640 and 40 mL of the
CellTiter reagent had been added. After incubation for 3 hours,
2 separate 100 mL aliquots of media from each sample were
transferred to a 96-well plate, and the optical absorbance at
490 nm was read, providing 2 readings per chamber. The read-
ings were averaged for each chamber. For descriptive and mor-
phologic analysis, the invasion chamber membranes were
stained with the Hema-3-stain kit (22-122911; Thermo Fisher
Scientific, Waltham, Massachusetts) and later viewed with and
imaged with a Olympus Vanox microscope at 20 magnifica-
tion. The percent invasion and invasion indices (InIs) were cal-
culated for each group in the following manner:
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Percent invasion ¼ Absorbance of cells penetrating Matrigel insert
Absorbance of cells penetrating control insert
Invasion index; InI ¼ Percent invasion of treatment group
Percent invasion of non stimulated group
The InIs for the different treatment arms were then compared
using a 1-way analysis of variance with Bonferroni corrections
for multiple comparisons. P < .05 was considered significant.
Placental Tissue Collection
Placental tissue was identified from patients who had previ-
ously given informed consent to participate in the Duke Preg-
nancy and Tissue Repository (Duke IRB Number,
Pro000011659). Placentas were collected at the time of deliv-
ery, and 1-in2 tissue samples from the placenta were obtained
using sterile scissors. These samples were then placed in opti-
mal cutting temperature (OCT) media and immediately frozen
and stored at 80C.
Placental Immunohistochemistry for AM
Placental tissue samples from 11 smokers and 11 nonsmokers
(self-reported smoking status) who delivered at term were pre-
pared for immunohistochemistry (IHC). Tissue samples were
thawed, fixed in formalin, sectioned, mounted, and paraffin
embedded on slides with deidentified labels to blind both pre-
parers and reviewers of the tissue sections. The samples were
then deparaffinized and prepared for IHC using the UltraVision
LP Detection System’s (TL-125-HD; Thermo Scientific, Fre-
mont, California) standard protocol. The primary antibody used
was a mouse monoclonal anti-AM antibody (AB-18092,
Abcam, Cambridge, Massachusetts) at a 1:100 dilution. This
was incubated overnight at 4C. Sections of amnion were used
as a positive control for the staining process. Negative controls
were sections of placental tissue incubated with the IHC
reagents in the absence of the primary antibody as well as sec-
tions of placental tissue incubated with AM primary antibody
that had been preabsorbed with AM peptide. After completion
of the IHC staining protocol, the sections were counterstained
with hematoxylin.
For each patient, we imaged 10 random 20 fields with a
Zeiss Axio Imager microscope. Three independent blinded
reviewers scored all digital images using a standardized semi-
quantitative 4-point scale for intensity of AM immunoreactiv-
ity in the syncytiotrophoblasts of the tertiary villi (1, nominimal
staining; 2, low-moderate staining; 3, high-moderate staining;
4, strong staining; Supplemental Figure 1). Once scoring was
complete, the results were unblinded and tabulated into a
cumulative score for each patient sample. For statistical analy-
sis, the mean score for each group was calculated and com-
pared using a Student t test after confirming normalcy of the
distribution of scores in each group with a Kolmogorov-
Smirnov test for normalcy. Statistical analysis for demographic
factors of the patient samples including maternal age, gesta-
tional age at delivery, and birthweight were also performed
using Student t tests as well. P < .05 was considered significant.
Real-Time Polymerase Chain Reaction
To determine whether the placentas of smokers demonstrated
greater ADM gene expression compared to the placentas of
nonsmokers, quantitative real-time polymerase chain reaction
(RT-PCR) was performed. Placental samples from 11 smokers
and 11 nonsmokers (same samples utilized for IHC) were
obtained, and total RNA was extracted from each sample using
an RNeasy Mini kit (QIAGEN, Valencia, California). Following
RNA extraction, RNA concentrations were calculated using the
Nanodrop ND-1000 spectrophotometer. A reverse transcription
reaction was performed to create complementary DNA using
Superscript III (Invitrogen, Carlsbad, California) first strand
synthesis system. Reverse transcription quantitative RT-PCR
was performed with a Bio-Rad iCycler (Bio-Rad, Hercules, Cali-
fornia) using the SYBR green detection method. Primer pairs
(Eurofins MWG Operon, Huntsville, Alabama) utilized for
ADM were forward (50-30) ATGAAGCTGGTTTCCGTCG and
reverse (50-30) GCCCACTTATTCCACTTCTTTCG and for
GAPDH forward (50-30) CATGAGAAGTATGACAACAGCCT
and reverse (50-30) AGTCCTTCCACGATACCAAAGT. ADM
cycle threshold values were normalized to GAPDH and analyzed
using the Pfaffl model with mean fold change reported and com-
pared using Student t test.22
Results
Nicotine Content of CSE
CSE has been used widely as a model to study the effects of
cigarette smoking on biologic processes.23 Only the respiratory
tract is exposed to aerosolized cigarette smoke; the other in
vivo tissues are not directly exposed to cigarette smoke but
rather to its soluble components. CSE treatment of cells in cul-
ture mimics this by exposing cells to thousands of soluble com-
ponents of cigarette smoke.24 Similar to other groups, we
measured the nicotine content in our 100% CSE as a method
to standardize exposure to the various components in CSE.
After measuring the nicotine content by high-performance
liquid chromatography of our 100% CSE preparation, we chose
to utilize a CSE dilution of 1%, which estimates the nicotine
exposure seen in a heavy smoker (1-2 packs per day leads to
nicotine blood levels of approximately 200 ng/mL).18 Further-
more, prior work from our lab demonstrated that 1% CSE
treatment of HTR-8/SVneo trophoblast cells lead to enhan-
ced cellular growth that was dependent on AM.10 The CSE
allows for a good model of the effects of cigarette smoke on
tissues, although identifying the individual component of
CSE that leads to the changes in biologic behavior would be
difficult.24
The concentration of nicotine in CSE preparations was deter-
mined in order to standardize CSE concentrations between
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Figure 1. Effect of AM and CSE on trophoblast invasion. Matrigel invasion assay was performed to evaluate HTR-8/SVneo cell invasion in the
presence of varying treatments. Images represent 20 fields of Matrigel-coated 8 mm pore PET membranes after removing all noninvasive cells.
A, Representative example of HTR-8/SVneo cells (stained purple) that invaded through the Matrigel and migrated through the PET membrane in
nonstimulated (left) and AM inhibitor-treated conditions (right). B, Representative images demonstrating HTR-8/SVneo cellular invasion in AM
treated (left) and AMþ AM inhibitor cotreatment (right). AM enhanced cellular invasion compared to nonstimulated cells (panel B compared to
panel A), and this was reversed with AM-inhibitor cotreatment. C, Representative example of HTR-8/SVneo cells treated with 1% CSE (left) and
cells cotreated with 1% CSE and AM inhibitor (right). CSE treatment of cells enhanced invasion compared to nonstimulated cells (panel C com-
pared to panel A), and this was reversed with AM-inhibitor cotreatment. AM indicates adrenomedullin; CSE, cigarette smoke extract; PET, poly-
ethylene terephthalate.
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individual CSE collections and to determine the appropriate
dose of CSE to use in experiments. High-performance liquid
chromatography analysis of 100% smoke extract showed a mean
nicotine concentration of 13 363 ng/mL. The nicotine content
from 1% CSE dilution was 130 ng/mL and is equivalent to that
found in the serum of a heavy smoker (100-200 ng/mL).18
CSE Increases Trophoblast Invasion via an
AM-Mediated Pathway
A Matrigel-based invasion assay was performed to test the
effects of CSE on HTR-8/SV neo trophoblast cell invasion.
Increased cellular invasion through Matrigel-coated membranes
was seen in cells each treated with AM (Figure 1B) or CSE
(Figure 1C) when compared to NS cells or cells treated with the
AM inhibitor alone (Figure 1A). The addition of the AM inhibi-
tor to either AM- or CSE-treated cells attenuated the increased
invasion seen with AM or CSE alone (Figure 1B and C).
The InIs were calculated for all the treatment groups, setting
the NS cells as the reference group with an InI of 1 and are sum-
marized in Figure 2. Calculation of an InI accounts for the
potential effects that the treatments may have on cellular
migration as well as cellular invasion. Cells treated with either
AM or CSE demonstrated increased invasion compared to NS
cells (InI 1.51-fold or 1.45-fold, respectively, P < .01 when
each compared to NS). Cotreatment of cells with AM and the
AM inhibitor significantly attenuated the increased invasion
seen with AM treatment alone (1.51- vs 0.96-fold, P < .05).
Moreover, a similar effect was found when CSE-treated cells
were cotreated with the AM inhibitor. Comparison of the InIs
of cells treated with CSE alone compared to cells cotreated
with CSE and the AM inhibitor was significant (1.45 vs 0.86,
P < .001), suggesting that inhibition of the AM pathway can
reverse the increased invasion seen with CSE treatment of tro-
phoblast cells.
Placental AM Protein and Gene Expression Levels Are
Increased Among Smokers
To determine whether AM protein expression varies within the
placentas of smokers compared to nonsmokers, we performed
IHC for AM on sections obtained from term placentas. There
were no significant differences in gestational age at delivery or
newborn birthweight between smokers and nonsmokers from
whom placental samples were obtained. The smokers were
younger compared to nonsmokers (mean age 24.7 vs 30.9 years,
P ¼ .02 for difference in means), and there was no difference in
mode of delivery between the 2 groups (Table 1).
Placentas from both smokers and nonsmokers demonstrated
positive immunostaining for AM in the villous syncytiotropho-
blasts (Figure 3A). The intensity of AM staining, when mea-
sured using a 4-point semiquantitative intensity scale
(Supplemental Figure 1) was significantly higher in smokers
compared to nonsmokers (Figure 3B, P ¼ .004). When the
results were analyzed individually from each of the 3 observ-
ers, the results were similar. Staining was noted in the amnion
layer as a positive control (Supplemental Figure 1). Negative
controls incubated both without the primary antibody (Supple-
mental Figure 1) or with primary AM antibody preabsorbed
with AM peptide (not shown) failed to demonstrate staining.
Using real-time quantitative PCR, mean ADM gene expres-
sion was 3.3-fold greater in the placentas of smokers compared
Figure 2. Summary data comparing invasion indices of HTR-8/SVneo
cells by treatment type. Invasion indices account for the number of
cells that invade through the Matrigel insert among different treatment
groups, as well as the number of cells that migrate through a control
insert in different treatment groups (see Methods section), were cal-
culated and compared by treatment group. The invasion index of NS
cells was set at 1. Treatment with the AM inhibitor (Inh) alone had no
significant (ns) effect on the invasion index. Both AM and CSE treat-
ments increased cellular invasion compared to NS controls by 1.5- and
1.4-fold, respectively (**P < .01). Cotreatment of cells with AM and AM
inhibitor (AM þ Inh) significantly reduced invasion compared to AM
alone (*P < .05). Cotreatment of cells with CSE and AM inhibitor (CSE
þ Inh) significantly reduced the increased invasion seen with CSE treat-
ment alone (***P < .001). Summary data represents 4 independent
experiments. Comparisons made using analysis of variance with Bonfer-
roni corrections for multiple comparisons. AM indicates adrenomedul-
lin; CSE, cigarette smoke extract; NS, nonstimulated.
Table 1. Clinical Characteristics of Patients From Whom Placentas





(n ¼ 11) P Valuea
Age, yearsb 30.9 + 5.6 24.7 + 6.0 .02
Cesarean delivery, n (%) 10 (90.9) 7 (63.6) .31
Gestational age delivery,
weeksb
39.2 + 0.9 39.2 + 1.5 1.0
Birthweight, gb 3312 + 406 3141 + 561 .4
Abbreviation: SD, standard deviation.
a Student t test for continuous variables; chi-square for categorical variables.
b Values are mean + SD.
Kraus et al 67
to the placentas of nonsmokers (P ¼ .022 for difference in
mean fold change).
Discussion
In this study, we demonstrate that the treatment of a first-
trimester cytotrophoblast cell line with 1% CSE increases cell
invasion through a Matrigel layer compared to NS controls, and
that this increased invasion can be reversed by cotreatment
with the competitive inhibitor to the AM receptor. Moreover,
treatment of the same cells with AM alone also caused
increased invasion in a similar manner to CSE treatment, and
this increased invasion with AM was also reversed by cotreat-
ment with the competitive AM inhibitor. Prior work from our
laboratory has demonstrated that treatment of HTR-8/SVneo
cells with 1% CSE increases cellular AM production, while
treatment with nicotine alone had no effect.10 Taken together,
these results suggest that CSE leads to increased invasiveness
of HTR-8/SVneo cells by causing the cells to increase endo-
genous production of AM.
Our study did not address potential mechanisms by which CSE
enhances cellular invasion that is mediated by AM, though recent
work in a lung cancer model implicates aryl hydrocarbon receptor
(AHR) activation.25 Portal-Nuñez et al demonstrated that CSE
treatment of lung cancer cells in vitro lead to a dose- and time-
dependent increase in AM production that was mediated by AHR
activation. Furthermore, cigarette smoke enhanced lung cancer
growth by activating the AHR, which increased cellular produc-
tion of AM. Cigarette smoke-dependent tumor growth was then
reversed with AM receptor antagonist cotreatment.25 Their work
provides further evidence that cigarette smoke enhances cellular
production of AM, which then affects cellular growth.
The placentas of murine fetuses lacking the AM gene
(ADM) exhibit typical pathological features of preeclampsia.26
The fetal labyrinth vessels within the placenta of these mice
demonstrate reduced branching. Furthermore, the number of
Figure 3. Immunohistochemistry for AM expression in term placentas from smokers and nonsmokers. A, Representative examples of 20
images from term placentas stained with antibodies directed against AM from a nonsmoker (top) and smoker (bottom). The placenta from the
smoker demonstrates enhanced staining for AM compared to the nonsmoker. B, Three independent, blinded observers evaluated 10 images
from each patient (n ¼ 22) and scored the intensity of AM staining using a 4-point scale (Supplemental Figure 1). A mean score intensity was
obtained for each patient and then after unblinding, a mean score was calculated for the smokers and nonsmokers groups and compared using a
Student t test. Placentas from smokers demonstrated enhanced AM staining compared to nonsmokers (P¼ .004). AM indicates adrenomedullin.
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decidual natural killer (NK) cells is reduced with a concomitant
decrease in the remodeling of maternal spiral arterioles.26 The
findings from mice lacking ADM demonstrate the importance
of AM for normal placental development.
The most commonly accepted theory for the development
of preeclampsia is that poor placental development and inade-
quate trophoblast-mediated remodeling of the spiral arterioles
results in reduced placenta perfusion, which increases oxidative
stress, resulting in the release of antiangiogenic factors causing
maternal systemic endothelial dysfunction.3 We propose that
cigarette smoking enhances placental trophoblast invasion (by
increasing cellular production of AM), which may improve
placental function and improve spiral arteriole remodeling,
thereby decreasing placental release of antiangiogenic factors,
which have been implicated in preeclampsia.3,26,27
Multiple studies have demonstrated that smoking during
pregnancy reduces the risk of developing preeclampsia by
approximately 50%.5,6,28,29 Wikstrom et al evaluated preeclamp-
sia risk in smokers and found that the risk reduction did not apply
to women who smoked in the first trimester but quit by the onset
of the third trimester, rather smoking throughout pregnancy pro-
vided greatest protection.6 Moreover, the same group found that
the use of smokeless tobacco (ie, snuff) conferred no protection
from preeclampsia.6 Finally, our group has shown that nicotine
treatment of trophoblast cells did not affect cell viability, migra-
tion, or AM production, while CSE treatment enhanced cellular
viability and migration, both of which were dependent on AM.10
These findings suggest that smoking throughout pregnancy is
required to maintain protection, and that nicotine products do not
provide similar protection.
To determine whether AM expression was enhanced in term
placental tissue of smokers, we performed IHC staining
directed at AM and real-time PCR for ADM gene expression
in the placentas of smokers and nonsmokers. Our results
demonstrate that the trophoblast cells in the tertiary villi of
smokers express more AM at term than the same tissue from
nonsmokers. Another group demonstrated decreased placental
AM production in placentas obtained from preeclamptic
women compared to nonpreeclamptics.17 Our findings,
together with the findings of Kanenishi et al, suggest that smok-
ing’s protection against the development of preeclampsia may
be partially mediated by increased placental production of AM.
As placental AM expression is higher in term placentas from
smokers compared to nonsmokers, this offers 1 possible
mechanism as to how a third-trimester alteration in placental
physiology may be an associated factor in the pathogenesis
of preeclampsia.
The AM is highly expressed throughout the reproductive
tract including the endometrium, fetal membranes, and pla-
centa. Originally described for its vasodilatory properties,
AM has been shown to have angiogenic, growth inducing,
immunomodulatory, and antimicrobial properties. With regard
to AM’s role in reproduction, Caron et al have shown that
AM knockout mouse pups die in midgestation with a hydropic
phenotype, and that the placentas of these mice show reduced
fetal vessel branching and reduced decidual NK cells resulting
in decreased remodeling of the maternal spiral arterioles,
both of which are quintessential pathologic findings of pree-
clampsia.14,26,30,31 The AM plasma levels rise over the course
of gestation in normal pregnancies, but there are conflicting
data about plasma levels of AM in preeclamptic pregnancies.32
Possible explanations for the conflicting data include different
patient phenotypes and differences in sample processing or
assays used to measure AM levels. Researchers who have
found increased AM levels in pregnancy theorize that the rise
in AM is a compensatory vasodilatory response attempting to
counteract the vasospasm at the root of preeclamptic hyperten-
sion.33 Conversely, theories as to how lower circulating AM
levels fit with the pathogenesis of the disease focus on the
decreased paracrine vasodilation as one of the root causes of
the preeclamptic phenotype.34 However, the predominant
rationale for these explanations is based on the function of
AM as a vasodilator, without consideration for the local effects
of AM peptide on trophoblast cells of the placenta.
Adrenomedullin 2 (ADM2), which is also known as inter-
medin, is a 47-amnio acid peptide that contains some structural
homology to AM.35 It is also expressed widely in the reproduc-
tive tract and has also been shown to increase trophoblast cel-
lular invasion.20 Furthermore, infusion of an ADM2 antagonist
to pregnant mice leads to fetal growth restriction.36 It is
unknown whether CSE treatment of trophoblast cells affects
ADM2 production and cellular invasion but is certainly an
important area of future research.
Cigarette smoking has also been shown to affect other angio-
genic markers that are implicated in preeclampsia.10,18 Soluble
fms-like tyrosine kinase 1 (s-Flt1) is the soluble form of the vas-
cular endothelial growth factor (VEGF) receptor. The s-Flt1
binds free serum VEGF, preventing VEGF signaling, thereby
acting as a VEGF antagonist.37 Women with preeclampsia have
been found to have elevated levels of s-Flt1, whereas pregnant
smokers have lower levels of s-Flt1.38 Furthermore, there is a
reduction in the secretion of s-Flt1 from term placental explants
treated with CSE in culture.18 Together, this suggests that in
addition to the effects of AM on trophoblast function, cigarette
smoking also likely decreases the risk of preeclampsia by its
affect on serum angiogenic factors.10,18,38
This study, in addition to prior work in our lab, is one of the
first to address the role of AM in explaining the protective
effect of smoking on the development of preeclampsia.10 We
used an immortalized trophoblast cell line in a Matrigel-
based assay in order to model early placental function, mainly
trophoblast invasion through the maternal decidua. This cell
line, which arose spontaneously from primary cultures of nor-
mal first-trimester chorionic villous samples, has been shown
to retain its phenotypic function.19 Despite some of the limita-
tion of CSE, CSE treatment of cell culture is recognized as a
robust model for studying the effects of smoking.24 This study
lends further evidence to the idea that the AM pathway is acti-
vated by CSE due to the finding that increased cell invasion
with CSE was attenuated by cotreatment with the AM inhibitor.
Prior work has demonstrated that the AM inhibitor works
directly on the AM receptor, although additional off target
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effects cannot be completely excluded here.39 However, in our
study the fact that AM inhibitor treatment of trophoblast cells
alone did not alter invasion compared to NS controls is reassur-
ing that off target effects, if they exist, are minimal. Loss-of-
function experiments where AM is competitively blocked or
the receptor is knocked down will be conducted to determine
specificity of the observed relationship.
In summary, we have demonstrated that treatment of a first-
trimester cell line with CSE increases cell invasion through an
AM-mediated process, and that placental AM levels are
increased among smokers at term compared to nonsmokers.
Smoking throughout pregnancy is required for protection from
preeclampsia. Here, we model early placental development with
the Matrigel assay and then demonstrate in third-trimester pla-
centas that AM placenta expression is increased among smokers.
Together, the increased invasiveness of trophoblast cells treated
with CSE concentrations typical of heavy smoking may lead to
improved placentation, and continued placental production of
AM throughout pregnant may, in part, explain how smoking pro-
tects against the development of preeclampsia.
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